Effect of blood cyclosporine concentration on the outcome of hematopoietic stem cell transplantation from an HLA-matched sibling donor-Reference-Cited by-同舟云学术

Effect of blood cyclosporine concentration on the outcome of hematopoietic stem cell transplantation from an HLA-matched sibling donor

Published:2006 Issue:11 Volume:81 Page:838-844
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Kanda Yoshinobu,Hyo Rie,Yamashita Takuya,Fujimaki Katsumichi,Oshima Kumi,Onoda Masahiro,Mori Takehiko,Sakura Toru,Tanaka Masatsugu,Sakai Miwa,Taguchi Jun,Kurakawa Mineo,Maruta Atsuo,Okamoto Shinichiro,Sakamaki Hisashi,

Publisher

Wiley

Subject

Hematology

Reference11 articles.

1. A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow Transplantation (EBMT)

2. Increased incidence of acute graft-versus-host disease with the continuous infusion of cyclosporine A compared to twice-daily infusion

3. Comparison of a Monoclonal Antibody Fluorescent Polarization Immunoassay with Monoclonal Antibody Radioimmunoassay for Cyclosporin Determination in Whole Blood

4. Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000)

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reaching the cyclosporine a level target slowly in four weeks correlates with better prognosis for Chinese patients after allogeneic haematopoietic cell transplantation;Hematology;2023-11-17

2. Outcomes and challenges treating pediatric acute myeloid leukemia: a retrospective analysis of patients treated at the Fundación Valle del Lili between 2011 and 2020;Hematology, Transfusion and Cell Therapy;2023-10

3. Assessment of risk factors for acute graft-versus-host disease post-hematopoietic stem cell transplantation: a retrospective study based on a proportional odds model using a nonlinear mixed-effects model;Therapeutic Advances in Hematology;2023-01

4. Toward optimization of cyclosporine concentration target to prevent acute graft‐versus‐host disease following myeloablative allogeneic stem cell transplant;Clinical Transplantation;2022-06-02

5. Risk factors and incidence of cytomegalovirus viremia and disease in pediatric patients with allogeneic hematopoietic stem cell transplantation: An 8‐year single‐center experience in Latin America;Pediatric Transplantation;2022-06